Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ME - 23andMe Holding Co.

IEX Last Trade
3.23
-0.020   -0.619%

Share volume: 2,900
Last Updated: Thu 26 Dec 2024 08:30:17 PM CET

PREVIOUS CLOSE
CHG
CHG%
$3.25
-0.02
-0.62%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.25%
1 Month
0.32%
3 Months
896.23%
6 Months
692.50%
1 Year
243.71%
2 Year
43.44%
Key data
Stock price
$3.23
P/E Ratio 
-0.17
DAY RANGE
$3.16 - $3.30
EPS 
-$1.30
52 WEEK RANGE
$0.29 - $5.50
52 WEEK CHANGE
$241.71
MARKET CAP 
106.909 M
YIELD 
N/A
SHARES OUTSTANDING 
339.503 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.65
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$222,722
AVERAGE 30 VOLUME 
$279,395
Company detail
CEO: Anne E. Wojcicki
Region: US
Website: 23andme.com
Employees: 770
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The company was founded in 2006 and is headquartered in South San Francisco, California.

Recent news